Drug Trial Radar · NCT06798727
Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control
Last checked: Nov 19, 2026Latest source record: Feb 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
84
Actual
Start
Mar 20, 2023
Primary completion
Mar 20, 2027
Study completion Nov 30, 2027
Sponsor
- Lead sponsor
- Medipost Co Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 29, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a follow-up study to investigate the long-term safety and explore efficacy of SMUP-IA-01, for the treatment of Knee Osteoarthritis. Subjects who participated in and completed the initial stage of the Phase II trial (NCT05182034) will be followed-up until 60 months.
Conditions
- Knee Osteoarthritis
Interventions
SMUP-IA-01(low-dose)Biological
A single knee administration of SMUP-IA-01(low-dose, 4.0 x 10\^6 cells/2mL)
SMUP-IA-01(mid-dose)Biological
A single knee administration of SMUP-IA-01(mid-dose, 1.0 x 10\^7 cells/2mL)
High Hyal PlusDrug
A single knee administration of Hyaluronic acid(1% Sodium Hyaluronate 20mg/2ml)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change of total score in WOMAC (Western Ontario and McMaster University)Time frame: Time Frame: Month 12, 24, 36, 48 and 60 after treatment
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Seoul Nation University Bundang Hospital
Gyeonggi-do, South Korea
Gangnam Severance Hospital
Seoul, South Korea
Korea University Anam Hospita
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Severance Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.